TFX (Teleflex) Company Future Sales Volume

Graphic logo of Teleflex Corp (TFX)

The current sales forecast level demonstrates the R&D potential in interventional urology and minimally invasive surgery, with the parameter value reaching 3.24. Simultaneously, Teleflex Incorporated (TFX) is implementing eco-friendly sterilization and reducing plastic in its packaging. Strong pricing power in the critical care segment and inelastic demand for unique consumables ensure the company's financial stability.

Company Future Sales Volume: Teleflex Corp (TFX) for 07/04/2022 - 11/13/2026

Teleflex Inc. (TFX) - metric breakdowns and financial figures

- stock value and consensus price forecast:
- business market valuation indicators:
Summary company analysis:TFX Teleflex Incorporated
Signature product of Teleflex Corp

This indicator measures the consensus forecast of future cash inflows, allowing for an assessment of revenue predictability and the business model's resilience to external shocks. By analyzing the projected sales chart for Teleflex Incorporated (TFX), an investor can confirm the stability of demand for Teleflex Incorporated (TFX) surgical instruments amid the global increase in elective surgeries and the expansion of healthcare networks.

Main competitors

Company Projected Revenue Intuitive Surgical (ISRG)|DHR (danaher.com) - Company Future Revenue|Becton Dickinson - Company Future Sales Volume|Projected Sales Volume STERIS PLC STE|WST - Company Projected Revenue|Baxter Healthcare (BAX) - Company Future Sales Volume|MASI: Projected Sales Volume|Company Expected Sales Volume stevanatogroup.com (STVN)|Company Projected Revenue Merit Medical|Company Revenue Forecast NVST (Envista Holdings Corporation)|Company Future Sales Volume ICUI (ICU Medical Corp)|Company Projected Revenue Volume XRAY|Company Projected Revenue LeMaitre Vascular, Inc. LMAT|Company Future Sales atricure.com (ATRC)|STAA: Company Future Sales Volume|ChromaDex Corp. - Company Projected Revenue Volume|ZIMV: Projected Sales Volume|Company Expected Sales Volume AngioDynamics Inc. (ANGO)|Company Projected Revenue Cerus Corporation|Company Projected Revenue TKNO|Projected Sales Volume MGRM|STSS - Company Expected Sales Volume|Projected Sales Volume INFU (InfuSystem Holdings, Inc.)|UTMD (Utah Med) - Company Expected Revenue|KRMD - Company Projected Revenue|NYXH: Company Projected Revenue|MBOT: Projected Sales Volume|Company Expected Sales Volume Pro-Dex Inc (PDEX)|Company Future Sales Volume ZTEK|Company Revenue Forecast ELUT (Elutia Corporation)|Company Future Sales Volume MLSS (Milestone Scientific)|NXGL (nexgel.com) - Company Future Revenue|Projected Sales Volume RVP (Retractable Technologies, Inc.)|Company Future Sales Harvard Bioscience Inc. (HBIO)|FEMY - Company Projected Revenue|MHUA (MeihuaMed) - Company Revenue Forecast|POAI: Projected Sales Volume|Company Future Sales Volume Callan JMB|Company Projected Revenue Atrion|Company Expected Sales Volume NeuroMetrix Inc NURO